• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名严重肥胖的年轻男性患者切除多发性肝细胞腺瘤的病例。

Case of resected multiple hepatocellular adenomas in a young man with severe obesity.

作者信息

Oji Kentaro, Urade Takeshi, Iwatani Yoshiteru, Tanaka Katsuhide, Hirano Hirotaka, Sanuki Tsuyoshi, Tomita Masaru, Yamamoto Yuki, Zen Yoh, Kuroda Daisuke

机构信息

Department of Surgery and Digestive Surgery, Kita-Harima Medical Center, 926-250, Ichiba-cho, Ono, 675-1392, Japan.

IHU Strasbourg Institute of Image-Guided Surgery, 1, Place de l'Hôpital, 67091, Strasbourg, CEDEX, France.

出版信息

Surg Case Rep. 2019 Aug 13;5(1):131. doi: 10.1186/s40792-019-0689-3.

DOI:10.1186/s40792-019-0689-3
PMID:31410698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6692803/
Abstract

BACKGROUND

Hepatocellular adenoma (HCA) is a rare liver tumor that has the potential for rupture and malignant transformation. Here, we report a case of multiple hepatocellular adenomas (HCAs) that were treated by surgical resection.

CASE PRESENTATION

An 18-year-old man was admitted to our hospital with proteinuria. His height was 176.5 cm, weight was 126 kg, and body mass index was 40 kg/m. A liver tumor was incidentally found on abdominal ultrasonography. Contrast-enhanced computed tomography and gadoxetic acid-enhanced magnetic resonance imaging revealed three hepatic tumors that were 68 mm, 16 mm, and 9 mm in segments 3/4, 8, and 1, respectively. A percutaneous needle biopsy of the largest tumor was performed, the diagnosis of unclassified type HCA was made, and laparoscopic partial liver resection was performed of all three. The postoperative course was uneventful, and the patient was discharged 12 days later. An immunohistochemical examination revealed positivity for serum amyloid A protein, no decrease in fatty acid-binding protein, and negativity for β-catenin, glutamine synthetase, and cytokeratin 7. Therefore, these tumors were diagnosed as inflammatory type HCAs.

CONCLUSIONS

We reported an extremely rare case of multiple resected HCAs in a young, obese Japanese man. Our findings suggest that HCA should be considered in the differential diagnosis of liver tumor in obese patients. Further studies that consider clinical and molecular risk factors are required to establish individualized treatment plans for HCA in obese patients.

摘要

背景

肝细胞腺瘤(HCA)是一种罕见的肝脏肿瘤,有破裂和恶变的可能。在此,我们报告一例通过手术切除治疗的多发性肝细胞腺瘤(HCA)病例。

病例介绍

一名18岁男性因蛋白尿入院。他身高176.5厘米,体重126千克,体重指数为40千克/平方米。腹部超声偶然发现肝脏肿瘤。对比增强计算机断层扫描和钆塞酸增强磁共振成像显示,分别在第3/4、8和1段有三个肝肿瘤,大小分别为68毫米、16毫米和9毫米。对最大的肿瘤进行了经皮穿刺活检,诊断为未分类型HCA,并对所有三个肿瘤进行了腹腔镜部分肝切除术。术后过程顺利,患者12天后出院。免疫组织化学检查显示血清淀粉样蛋白A呈阳性,脂肪酸结合蛋白无降低,β-连环蛋白、谷氨酰胺合成酶和细胞角蛋白7呈阴性。因此,这些肿瘤被诊断为炎症型HCA。

结论

我们报告了一例极其罕见的年轻肥胖日本男性多发性切除HCA病例。我们的研究结果表明,肥胖患者肝脏肿瘤的鉴别诊断应考虑HCA。需要进一步考虑临床和分子危险因素的研究,以制定肥胖患者HCA的个体化治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/fc9c6d05e07a/40792_2019_689_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/4024a2c07df5/40792_2019_689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/b002220a517c/40792_2019_689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/bfcbb445336e/40792_2019_689_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/fc9c6d05e07a/40792_2019_689_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/4024a2c07df5/40792_2019_689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/b002220a517c/40792_2019_689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/bfcbb445336e/40792_2019_689_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b026/6692803/fc9c6d05e07a/40792_2019_689_Fig4_HTML.jpg

相似文献

1
Case of resected multiple hepatocellular adenomas in a young man with severe obesity.一名严重肥胖的年轻男性患者切除多发性肝细胞腺瘤的病例。
Surg Case Rep. 2019 Aug 13;5(1):131. doi: 10.1186/s40792-019-0689-3.
2
Successful resection of a huge hepatocellular adenoma.成功切除巨大肝细胞腺瘤。
Clin J Gastroenterol. 2021 Oct;14(5):1544-1549. doi: 10.1007/s12328-021-01486-4. Epub 2021 Jul 21.
3
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.伴有微小恶性转化灶的肝细胞腺瘤或恶性腺瘤切除术后的长期预后。
JHEP Rep. 2021 Jun 29;3(4):100326. doi: 10.1016/j.jhepr.2021.100326. eCollection 2021 Aug.
4
Beta-catenin-activated hepatocellular adenoma in a male.男性β-连环蛋白激活型肝细胞腺瘤。
Clin J Gastroenterol. 2021 Jun;14(3):831-835. doi: 10.1007/s12328-021-01372-z. Epub 2021 Mar 2.
5
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
6
Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.表达ASS1的未分类肝细胞腺瘤与炎症性肝细胞腺瘤相关。
Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):e63-e67. doi: 10.1016/j.clinre.2019.03.012. Epub 2019 Apr 30.
7
Clinicopathological features and post-resection outcomes of hepatocellular adenoma.肝细胞腺瘤的临床病理特征及切除术后结果
Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):25-33. doi: 10.14701/ahbps.2021.25.1.25.
8
Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.伴有β-连环蛋白激活的色素沉着性肝细胞腺瘤:病例报告及文献复习
Ann Hepatol. 2016 Jul-Aug;15(4):598-603.
9
Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.基于表型分类系统的肝细胞腺瘤的回顾性研究:来自中国的报告。
Histol Histopathol. 2014 Feb;29(2):243-9. doi: 10.14670/HH-29.243. Epub 2013 Aug 13.
10
Resection, transplantation and local regional therapies for liver adenomas.肝腺瘤的切除术、移植术及局部区域治疗
Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):803-10. doi: 10.1586/17474124.2014.917957. Epub 2014 Jun 24.

引用本文的文献

1
Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.钆塞酸二钠增强MRI肝胆期的肝腺瘤亚型:系统评价与Meta分析
AJR Am J Roentgenol. 2023 Jan;220(1):28-38. doi: 10.2214/AJR.22.27989. Epub 2022 Aug 3.
2
Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.病例报告:普瑞德-威利综合征患者的肝腺瘤。
Front Endocrinol (Lausanne). 2022 Mar 9;13:826772. doi: 10.3389/fendo.2022.826772. eCollection 2022.
3
From an Incidental Finding to an Emergent Treatment: A Case Report of a Hepatic Adenomatosis and Large Ruptured Hepatic Adenoma.

本文引用的文献

1
Current Approaches in the Management of Hepatic Adenomas.当前肝腺瘤的治疗方法。
J Gastrointest Surg. 2019 Jan;23(1):199-209. doi: 10.1007/s11605-018-3917-4. Epub 2018 Aug 14.
2
Regression of hepatocellular adenoma after bariatric surgery in severe obese patients.肥胖患者行减重手术后肝细胞腺瘤消退。
Liver Int. 2018 Dec;38(12):2134-2136. doi: 10.1111/liv.13934. Epub 2018 Aug 10.
3
Is bariatric surgery a potential new treatment for large inflammatory hepatocellular adenomas in obese patients?减肥手术是否是肥胖患者大型炎性肝细胞腺瘤的一种潜在新疗法?
从偶然发现到紧急治疗:一例肝腺瘤病合并巨大破裂肝腺瘤的病例报告
Case Rep Gastrointest Med. 2021 Jun 19;2021:9963440. doi: 10.1155/2021/9963440. eCollection 2021.
4
Is This Patient's Liver Mass Cancer?这位患者的肝脏肿块是癌症吗?
J Adv Pract Oncol. 2021 Jan-Feb;12(1):108-111. doi: 10.6004/jadpro.2021.12.1.9. Epub 2021 Jan 1.
Surg Obes Relat Dis. 2018 Apr;14(4):535-538. doi: 10.1016/j.soard.2018.01.006. Epub 2018 Jan 11.
4
Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group.腹腔镜与开腹肝切除术治疗肝细胞腺瘤的短期疗效:AFC-HCA-2013 研究组的多中心倾向评分调整分析。
Surg Endosc. 2017 Oct;31(10):4136-4144. doi: 10.1007/s00464-017-5466-4. Epub 2017 Mar 9.
5
European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.欧洲573例肝细胞腺瘤肝切除术的经验:AFC-HCA-2013研究组的横断面研究
HPB (Oxford). 2016 Sep;18(9):748-55. doi: 10.1016/j.hpb.2016.06.011. Epub 2016 Jul 22.
6
Laparoscopic Liver Resection can be an Effective Way in Obese Patients: A Single Center of 2-Year Experience.腹腔镜肝切除术对肥胖患者可能是一种有效的方法:单中心两年经验
Surg Laparosc Endosc Percutan Tech. 2016 Jun;26(3):e69-72. doi: 10.1097/SLE.0000000000000268.
7
Benefit of laparoscopic liver resection in high body mass index patients.腹腔镜肝切除术在高体重指数患者中的益处。
World J Gastroenterol. 2016 Mar 14;22(10):3015-22. doi: 10.3748/wjg.v22.i10.3015.
8
The management of hepatocellular adenoma in obese patients: issues to consider.肥胖患者肝细胞腺瘤的管理:需考虑的问题。
Liver Int. 2016 Jan;36(1):152. doi: 10.1111/liv.12968. Epub 2015 Oct 12.
9
Will weight loss become a future treatment of hepatocellular adenoma in obese patients?减肥会成为未来肥胖患者肝细胞腺瘤的一种治疗方法吗?
Liver Int. 2015 Oct;35(10):2228-32. doi: 10.1111/liv.12925. Epub 2015 Aug 28.
10
Malignant transformation of hepatocellular adenoma: how frequently does it happen?肝细胞腺瘤的恶性转化:其发生频率如何?
Liver Cancer. 2015 Mar;4(1):1-5. doi: 10.1159/000367726.